Organ Preservation Market 2025 | Size, Growth, and Forecast by 2033

Market Overview: The organ preservation market is experiencing rapid growth, driven by increasing organ transplants, advancements in preservation techniques, and aging population. According to IMARC Group’s latest research publication, “Organ Preservation Market Report by Preservation Solution (UW Solution, Custodiol HTK, Perfadex, and Others), Organ Donation Type (Living Organ Donation, Deceased Organ Donation), Technique (Static Cold Storage Technique, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, and Others), Organ Type (Kidney, Liver, Lung, Heart, and Others), End-User (Hospitals and Clinics, Organ Banks, and Others), and Region 2025-2033“, The global organ preservation market size was valued at USD 198.87 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 320.40 Million by 2033, exhibiting a CAGR of 5.39% from 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis. Grab a sample PDF of this report: https://www.imarcgroup.com/organ-preservation-market/requestsample Our report includes: 

• Market Dynamics
• Market Trends And Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Factors Affecting the Growth of the Organ Preservation Industry:

• Increasing Organ Transplants:

The rising number of organ transplant procedures is catalyzing the demand for organ preservation. Organ transplants are usually the only viable treatment for end-stage organ failures, such as kidney, liver, and heart diseases. As medical advancements improve surgical outcomes and increase the success rates of transplants, the demand for viable organs increases. This demand necessitates effective preservation methods to maintain organ functionality from donor to recipient. Additionally, with the increasing number of transplant centers and advancements in medical infrastructure, more patients are receiving transplants.

• Advancements in Preservation Techniques:

Innovations in organ preservation techniques are propelling the market growth. Advancements, such as hypothermic machine perfusion and normothermic perfusion, revolutionized the way organs are preserved. These techniques offer superior outcomes as compared to traditional static cold storage by providing continuous circulation of preservation solutions, which helps maintain organ viability and function for extended periods. Hypothermic machine perfusion lowers the organ’s temperature while ensuring nutrient and oxygen supply, reducing ischemic damage. On the other hand, normothermic perfusion maintains the organ at body temperature, enabling metabolic activity. These advanced methods improve transplant success rates and expand the donor pool by preserving marginal organs that would otherwise be unsuitable for transplantation.

• Aging Population:

The rising demand for organ preservation among the aging population is impelling the market growth. As people age, the prevalence of chronic diseases, such as diabetes, hypertension, and cardiovascular conditions increases, leading to a higher incidence of organ failure. Older adults often require organ transplants to treat these conditions, resulting in increased demand for preserved organs. Additionally, the aging population is facing age-related conditions, necessitating organ transplants. The increasing number of elderly patients on transplant waiting lists underscores the need for efficient preservation solutions to ensure that organs remain viable for transplantation. The organ preservation market report provides a comprehensive overview of the industry. This analysis is essential for stakeholders aiming to navigate the complexities of the biochar market and capitalize on emerging opportunities. Leading Companies Operating in the Global Organ Preservation Industry:

• 21st Century Medicine
• Biolife Solutions
• Bridge to Life Ltd.
• Bristol-Myers Squibb
• Dr. Franz Köhler Chemie GmbH
• Essential Pharmaceuticals.
• Lifeline Scientific
• OrganOx
• Paragonix Technologies
• TransMedics, Waters Medical Systems
• Xvivo Perfusion

Organ Preservation Market Report Segmentation:  By Preservation Solution:

• UW Solution
• Custodiol HTK
• Perfadex
• Others

UW solution represents the largest segment due to its exceptional ability to preserve organs during transplantation procedures. By Organ Donation Type:

• Living Organ Donation
• Deceased Organ Donation

Deceased organ donation represents the largest segment, as it allows for UW solution exhibits a clear dominance in the market due to its comprehensive ability to reduce cellular swelling and preserve multiple organ types. By Technique:

• Static Cold Storage Technique
• Hypothermic Machine Perfusion
• Normothermic Machine Perfusion
• Others

Static cold storage technique holds the biggest market share attributed to its simplicity and cost-effectiveness in preserving organs. By Organ Type:

• Kidney
• Liver
• Lung
• Heart
• Others

Kidney dominates the market, driven by their higher demand and frequency of transplants. By End-User:

• Hospitals and Clinics
• Organ Banks
• Others

Organ banks account for the majority of the market share accredited to their pivotal role in managing organ donations, storage, and distribution efficiently. Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America dominates the market owing to the presence of an advanced healthcare infrastructure and a high rate of organ donation and transplantation activities. Research Methodology: The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability. Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations. About Us: IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research. Contact US IMARC Group 134 N 4th St. Brooklyn, NY 11249, USA Email: sales@imarcgroup.com Tel No:(D) +91 120 433 0800 United States: +1-631-791-1145